BMC Endocrine Disorders Volume 2
|
Viewing options:Associated material:Related literature:- Articles citing this article
- Other articles by authors
- Related articles/pages
Tools:Post to:
|
 Research articleTreatment of hyperfunctioning thyroid nodules by percutaneous ethanol injectionBagher Larijani1 , Mohammad Pajouhi1 , Hossein Ghanaati2 , Mohammad-Hassan Bastanhagh1 , Fereshteh Abbasvandi1 , Kazem Firooznia2 , Mahmood Shirzad1 , Mohammad-Reza Amini1 , Maryam Sarai1 , Nasreen Abbasvandi1 and Reza Baradar-Jalili1  1Endocrinology & Metabolism Research Centre, Tehran University of Medical Sciences, Tehran, Iran 2Medical Imaging Centre, Imam Khomeini University Hospital, Tehran, Iran author email corresponding author email
BMC Endocrine Disorders 2002,
2:3doi:10.1186/1472-6823-2-3
|
|
| Published: |
6 December 2002 |
Abstract
Background
Autonomous thyroid nodules can be treated by a variety of methods. We assessed the efficacy of percutaneous ethanol injection in treating autonomous thyroid nodules.
Methods
35 patients diagnosed by technetium-99 scanning with hyperfunctioning nodules and suppressed sensitive TSH (sTSH) were given sterile ethanol injections under ultrasound guidance. 29 patients had clinical and biochemical hyperthyroidism. The other 6 had sub-clinical hyperthyroidism with suppressed sTSH levels (<0.24 μIU/ml) and normal thyroid hormone levels. Ethanol injections were performed once every 1–4 weeks. Ethanol injections were stopped when serum T3, T4 and sTSH levels had returned to normal, or else injections could no longer be performed because significant side effects. Patients were followed up at 3, 6 and, in 15 patients, 24 months after the last injection.
Results
Average pre-treatment nodule volume [18.2 ± 12.7 ml] decreased to 5.7 ± 4.6 ml at 6 months follow-up [P < 0.001]. All patients had normal thyroid hormone levels at 3 and 6 months follow-up [P < 0.001 relative to baseline]. sTSH levels increased from 0.09 ± 0.02 μIU/ml to 0.65 ± 0.8 μIU/ml at the end of therapy [P < 0.05]. Only 3 patients had persistent sTSH suppression at 6 months post-therapy. T4 and sTSH did not change significantly between 6 months and 2 years [P > 0.05]. Ethanol injections were well tolerated by the patients, with only 2 cases of transient dysphonia.
Conclusion
Our findings indicate that ethanol injection is an alternative to surgery or radioactive iodine in the treatment of autonomous thyroid nodules. |